$HUMA

Insider Buying Week 05-17-24 Biotech Bonanza

by

I was a little late in finishing the blog, as there were many more names to research. Most of the quarterly earnings are behind us, and it is heartening to see that insider buying has picked up a little. Speculative biotech is heating up.   Name: F Thomson Leighton Position: Chief Executive Officer Transaction Date: 2023-05-14 Shares Bought: 22,000 Average Price Paid: $92.68 Cost: $2,038,960 Company: Akamai Technologies Inc (AKAM) Akamai aims to empower and defend life online. Since 1998, Akamai has created and delivered technologies to help global businesses design, deliver, and protect their digital experiences on their widely … Read more

Insider Buying Week 9-7-22 The Seesaw was Heavy on the Short Side

by

Curious how well insiders are doing with their buys? Scroll through the blog posts and see for yourself Last week, the market reversed its sour mood with a thunderous rally propelling the S&P 500 by 3.52%. Our insider buys did even better, notching an average of 5.73% returns. Heavily shorted stock, no matter how poor their prospects doubled that. It was the classic case of everybody on the same side of the seesaw.  In keeping with the old adage, the market will figure out how to screw most people most of the time.   Name: Robert J Mylod Jr Position: … Read more